General Info:

Requip (Ropinirole) is one of the medicines used to treat Parkinson's disease.

The precise mechanism of action of REQUIP as a treatment for Parkinson's disease is unknown, although it is believed to be due to stimulation of postsynaptic dopamine D2-type receptors within the caudate-putamen in the brain.

Requip (Ropinirole) is the first FDA-approved medication for the treatment of moderate-to-primary restless legs syndrome or RLS.

RLS is a neurological movement condition characterized by a strong, compelling urge to move the legs, often accompanied by leg twitching and uncomfortable, sometimes painful, sensations in the legs. The symptoms of RLS are worse while sitting or lying down. The symptoms get better when the person moves around, but return when he or she sits or lies back down. Usually, the twitching legs, tingling legs, and other symptoms of RLS begin during the evening or at night.

Prescription Requip (Ropinirole) is not for everyone. Requip Tablets may cause you to fall asleep or feel very sleepy during normal activities such as driving; or to faint or feel dizzy, nauseated, or sweaty when you stand up.

In some patients, Requip has been proven to:

• Reduce the severity of symptoms after 2 nights with your starting dose
• Help relieve the urge to move at 9 months

For some people, getting the desired response may take longer than others. With Requip, most patients start feeling some relief within 2 weeks. Take Requip every day, the way your doctor prescribes it, even if you don't have symptoms every day.